Beyond the Tech Giants: 35 Non-Tech AI Opportunities

24. DaVita Inc. (NYSE:DVA)

Number of Hedge Fund Holders: 34     

DaVita Inc. (NYSE:DVA) provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. It also offers outpatient, hospital inpatient, and home-based hemodialysis services, and operates clinical laboratories that provide routine laboratory tests for dialysis. The firm uses AI tools primarily to enhance patient care and operational efficiency in dialysis treatments. These AI tools help DaVita monitor patient health, predict treatment outcomes, and optimize care plans. The company has also integrated AI-driven tools to streamline administrative tasks, such as managing patient data and improving the accuracy of diagnoses.

DaVita Inc. (NYSE:DVA) is turning heads on Wall Street. Truist recently raised the price target on the stock to $165 from $150 and kept a Hold rating, noting that the price target raise reflected DaVita’s Q2 results and raised FY24 guidance. In an investor note, the advisory added that it continued to like the core dialysis business of the firm and acknowledged the potential opportunity tied to integrated care longer term.